Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics

The association of mutations in the PHD2 protein of the hypoxia-sensing pathway and erythrocytosis has only been established in the last decade. Here we report the case of a novel PHD2 gene mutation in a patient with erythrocytosis and summarize all reported cases to date. Case Report. A 55-year-old...

Full description

Saved in:
Bibliographic Details
Main Authors: Rachel Wilson, Nausheen Syed, Prabodh Shah
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2016/6373706
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850163888338763776
author Rachel Wilson
Nausheen Syed
Prabodh Shah
author_facet Rachel Wilson
Nausheen Syed
Prabodh Shah
author_sort Rachel Wilson
collection DOAJ
description The association of mutations in the PHD2 protein of the hypoxia-sensing pathway and erythrocytosis has only been established in the last decade. Here we report the case of a novel PHD2 gene mutation in a patient with erythrocytosis and summarize all reported cases to date. Case Report. A 55-year-old man presented with dyspnea and a previous diagnosis of idiopathic erythrocytosis. PHD gene sequencing revealed a mutation on exon 2. The mutation was recognized as p.(Trp334⁎) (c. 1001G>A) resulting in a truncation of a highly conserved amino acid residue in catalytic domain. A diagnosis of erythrocytosis secondary to mutant PHD2 gene was made. Conclusions. Our findings indicate that with PHD2 mutations there is moderate erythrocytosis and erythropoietin (Epo) levels are generally low to normal. Two patients with PHD2 substitution mutations were found to have paraganglioma and one of these patients had a concurrent pheochromocytoma. In addition, one mutation was associated with sagittal sinus thrombosis. Given the severity of some of the clinical features of these mutations, we conclude that clinical guidelines should include the PHD2 mutation in the idiopathic erythrocytosis workup.
format Article
id doaj-art-ecd5ef2fb0da4b50945a57355b71e30a
institution OA Journals
issn 2090-6560
2090-6579
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-ecd5ef2fb0da4b50945a57355b71e30a2025-08-20T02:22:06ZengWileyCase Reports in Hematology2090-65602090-65792016-01-01201610.1155/2016/63737066373706Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and GeneticsRachel Wilson0Nausheen Syed1Prabodh Shah2Chicago Medical School, North Chicago, IL, USAChicago Medical School, North Chicago, IL, USALittle Company of Mary Hospital, Evergreen Park, IL, USAThe association of mutations in the PHD2 protein of the hypoxia-sensing pathway and erythrocytosis has only been established in the last decade. Here we report the case of a novel PHD2 gene mutation in a patient with erythrocytosis and summarize all reported cases to date. Case Report. A 55-year-old man presented with dyspnea and a previous diagnosis of idiopathic erythrocytosis. PHD gene sequencing revealed a mutation on exon 2. The mutation was recognized as p.(Trp334⁎) (c. 1001G>A) resulting in a truncation of a highly conserved amino acid residue in catalytic domain. A diagnosis of erythrocytosis secondary to mutant PHD2 gene was made. Conclusions. Our findings indicate that with PHD2 mutations there is moderate erythrocytosis and erythropoietin (Epo) levels are generally low to normal. Two patients with PHD2 substitution mutations were found to have paraganglioma and one of these patients had a concurrent pheochromocytoma. In addition, one mutation was associated with sagittal sinus thrombosis. Given the severity of some of the clinical features of these mutations, we conclude that clinical guidelines should include the PHD2 mutation in the idiopathic erythrocytosis workup.http://dx.doi.org/10.1155/2016/6373706
spellingShingle Rachel Wilson
Nausheen Syed
Prabodh Shah
Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics
Case Reports in Hematology
title Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics
title_full Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics
title_fullStr Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics
title_full_unstemmed Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics
title_short Erythrocytosis due to PHD2 Mutations: A Review of Clinical Presentation, Diagnosis, and Genetics
title_sort erythrocytosis due to phd2 mutations a review of clinical presentation diagnosis and genetics
url http://dx.doi.org/10.1155/2016/6373706
work_keys_str_mv AT rachelwilson erythrocytosisduetophd2mutationsareviewofclinicalpresentationdiagnosisandgenetics
AT nausheensyed erythrocytosisduetophd2mutationsareviewofclinicalpresentationdiagnosisandgenetics
AT prabodhshah erythrocytosisduetophd2mutationsareviewofclinicalpresentationdiagnosisandgenetics